絞り込み

16501

広告

「"ann rheum dis"[Journal]」の検索結果

14464件中 141件~160件表示    検索結果をPubMedで見る PubMedで見る

2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea.

Inconsistency between Danish incidence and prevalence data about psoriatic arthritis (PsA).

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis.

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.

ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.

Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation.

Stratification of knee osteoarthritis: two major patient subgroups identified by genome-wide expression analysis of articular cartilage.

Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study.

Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate.

Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor.

Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al.

Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus.

Standard dose of Ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist.

Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden.

Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand.

Disease activity in ankylosing spondylitis: the global therapeutic target.

  1. 4
  2. 5
  3. 6
  4. 7
  5. 8
  6. 9
  7. 10
  8. 11
  9. 12
  10. 13
Sort by
※並べ替えは表示に時間がかかります